As more people are diagnosed with celiac disease, the first drug treatments are entering clinical trials. These drugs are geared toward supplementing, or even replacing, the gluten-free diet, which is currently the only treatment available. But success is proving difficult to measure.

Read this story at Pharmaceutical Journal.